Neuberger Berman Group »

Protalix Biotherapeutics shares owned by Neuberger Berman Group

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Neuberger Berman Group from 13F filings

Historical chart of Neuberger Berman Group investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by Neuberger Berman Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $25k 12k 2.17

More positions owned by Neuberger Berman Group

Nvidia Corp Common (NVDA)
Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Amazon Common (AMZN)
Alphabet Inc Class A A Common (GOOGL)
Alphabet Inc-cl C Common (GOOG)
Jpmorgan Chase & Co Common (JPM)
Eli Lilly & Co Common (LLY)
Ishares Core S&p 500 Etf Etf (IVV)
Meta Platforms Inc Class A A Common (META)
Broadcom Common (AVGO)
Nextera Energy Common (NEE)
Home Depot Common (HD)
Exxon Mobil Corp Common (XOM)
Asml Holding Adr Representing Nv Common (ASML)

View all positions for Neuberger Berman Group

Top funds holding Protalix Biotherapeutics

BlackRock
MAK Capital One
Renaissance Technologies
State Street Corporation
Northern Trust
Geode Capital Management
Stratos Wealth Partners
Vanguard Portfolio Management
Prospera Financial Services
Opaleye Management
Morgan Stanley
Dimensional Fund Advisors
OTR - Nominee Name for The State Teachers Retirement Board of Ohio
Susquehanna International
UBS Group

View all funds holding Protalix Biotherapeutics